SUSHIL JAIN: Open Payments
NPI 1538147152 · MEDINA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 20 payments from 10 companies in 2025. Trend: 2023 $222 · 2024 $386 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $153 |
| Xeris Pharmaceuticals, Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Insmed, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| PFIZER INC. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: AIRSUPRA, GVOKE HYPOPEN, FARXIGA, GEMTESA, Wegovy, Arikayce, Korlym, BREZTRI.
Industry payments across OH — which companies pay providers there.
